Pesquisas alternativas:
models develop » model develop (Expandir a Pesquisa), models developed (Expandir a Pesquisa), model develops (Expandir a Pesquisa)
develop type » developing type (Expandir a Pesquisa)
dna develop » 133a develop (Expandir a Pesquisa), cd38 develop (Expandir a Pesquisa), esau develop (Expandir a Pesquisa)
drug models » drug mode (Expandir a Pesquisa)
a develop » _ develop (Expandir a Pesquisa), 3 develop (Expandir a Pesquisa), a developed (Expandir a Pesquisa)
models develop » model develop (Expandir a Pesquisa), models developed (Expandir a Pesquisa), model develops (Expandir a Pesquisa)
develop type » developing type (Expandir a Pesquisa)
dna develop » 133a develop (Expandir a Pesquisa), cd38 develop (Expandir a Pesquisa), esau develop (Expandir a Pesquisa)
drug models » drug mode (Expandir a Pesquisa)
a develop » _ develop (Expandir a Pesquisa), 3 develop (Expandir a Pesquisa), a developed (Expandir a Pesquisa)
41
Por Wills, Lauren P., Trager, Richard E., Beeson, Gyda C., Lindsey, Christopher C., Peterson, Yuri K., Beeson, Craig C., Schnellmann, Rick G.
Publicado em 2012
Assuntos:
“...Drug Discovery and Translational Medicine...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
42
Por Sandi, Chiranjeevi, Sandi, Madhavi, Jassal, Harvinder, Ezzatizadeh, Vahid, Anjomani-Virmouni, Sara, Al-Mahdawi, Sahar, Pook, Mark A.
Publicado em 2014
“... and to hasten drug screening, the development and use of animal and cellular models is considered essential...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
43
“... and biochemical data to develop a model. In this model, several of the mutations associated with AZT resistance...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
44
Por Tanaka, Mamoru, Kataoka, Hiromi, Yano, Shigenobu, Ohi, Hiromi, Kawamoto, Keisuke, Shibahara, Takashi, Mizoshita, Tsutomu, Mori, Yoshinori, Tanida, Satoshi, Kamiya, Takeshi, Joh, Takashi
Publicado em 2013
“...BACKGROUND: Cisplatin (CDDP) is the most frequently used chemotherapeutic agent for various types...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
45
“...Mitomycin C (MMC) is a prototype bioreductive drug employed to treat a variety of cancers including...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
46
“... as either a lead compound for development of new TB drugs or as an adjunct in the current TB chemotherapy....”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
47
Por Chan, Raphael C. Y., Hui, Mamie, Chan, Edward W. C., Au, T. K., Chin, Miu L., Yip, Chun K., AuYeang, Carrie K. W., Yeung, Christina Y. L., Kam, Kai M., Yip, Peter C. W., Cheng, Augustine F. B.
Publicado no J Antimicrob Chemother (2007)
“... to the other drugs. A total of 102 novel mutations, which accounted for 80% of all mutation types detected...”Publicado no J Antimicrob Chemother (2007)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
48
Por Szalowska, Ewa, van der Burg, Bart, Man, Hai-Yen, Hendriksen, Peter J. M., Peijnenburg, Ad A. C. M.
Publicado em 2014
“...Although drug induced steatosis represents a mild type of hepatotoxicity it can progress into more...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
49
Por Philip Reigan, Brian G. Reid, Qiong Zhou, Amanda K. Ashley, Jac A. Nickoloff, Robert Hromas, Daniel V. LaBarbera, Courtney L. Amerin, Qun Li, Adedoyin D. Abraham, Byong Hoon Yoo, Jessica Ponder
Publicado em 2011-11-01
“...Marine Drugs...”Publicado em 2011-11-01
Obter o texto integral
Artigo
50
“... for promoting the development of certain types of cancer and a target for the prevention and therapy...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
51
Por Mizuarai Shinji, Yamanaka Kazunori, Itadani Hiraku, Arai Tsuyoshi, Nishibata Toshihide, Hirai Hiroshi, Kotani Hidehito
Publicado em 2009-06-01
“..., the development of a pharmacodynamic (PD) biomarker leveraging mRNA expression is eagerly anticipated in order...”Publicado em 2009-06-01
Obter o texto integral
Artigo
52
Por Mizuarai, Shinji, Yamanaka, Kazunori, Itadani, Hiraku, Arai, Tsuyoshi, Nishibata, Toshihide, Hirai, Hiroshi, Kotani, Hidehito
Publicado em 2009
“... small amount of biopsy tissue and is highly quantitative, the development of a pharmacodynamic (PD...”Publicado em 2009
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
53
Por Mellinas-Gomez, Maria, Spanswick, Victoria J., Paredes-Moscosso, Solange R., Robson, Matthew, Pedley, R. Barbara, Thurston, David E., Baines, Stephen J., Stell, Anneliese, Hartley, John A.
Publicado no BMC Vet Res (2015)
“.... There is clearly a need to develop more effective anti-cancer drugs in dogs. SG2000 (SJG-136) is a sequence...”Publicado no BMC Vet Res (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
54
“... agents due to emerging drug resistance. In this study, we developed a stochastic model of BRCA-associated...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
55
Por Cambau, Emmanuelle, Chauffour-Nevejans, Aurélie, Tejmar-Kolar, Liana, Matsuoka, Masanori, Jarlier, Vincent
Publicado em 2012
“... reverse hybridization DNA strip test was developed as the GenoType LepraeDR test. It includes DNA probes...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
56
Por García-Castillo, Verónica, López-Urrutia, Eduardo, Villanueva-Sánchez, Octavio, Ávila-Rodríguez, Miguel Á., Zentella-Dehesa, Alejandro, Cortés-González, Carlo, López-Camarillo, César, Jacobo-Herrera, Nadia J, Pérez-Plasencia, Carlos
Publicado no J Cancer (2017)
“... cells to develop drug resistance, highlighting the urgent need to design newer and safer drug...”Publicado no J Cancer (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
57
Por Saha, Sourav, Acharya, Chiranjit, Pal, Uttam, Chowdhury, Somenath Roy, Sarkar, Kahini, Maiti, Nakul C., Jaisankar, Parasuraman, Majumder, Hemanta K.
Publicado no Antimicrob Agents Chemother (2016)
“... of effective drugs against this neglected tropical disease. We report here the development of a novel...”Publicado no Antimicrob Agents Chemother (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
58
Por Ponder, Jessica, Yoo, Byong Hoon, Abraham, Adedoyin D., Li, Qun, Ashley, Amanda K., Amerin, Courtney L., Zhou, Qiong, Reid, Brian G., Reigan, Philip, Hromas, Robert, Nickoloff, Jac A., LaBarbera, Daniel V.
Publicado em 2011
“...Type IIα DNA topoisomerase (TopoIIα) is among the most important clinical drug targets...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
59
“... vaccine formulated in alum was tested for its prophylactic efficacy in a mouse model. It was observed...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
60
“... chemotherapy docetaxel advance the median overall survival of 12 months. These drugs have a different mechanism...”
Obter o texto integral
Obter o texto integral
Livro